Shukra Pharmaceuticals enterprise value

·Pharma & HealthChart ›
MultiplesEnterprise valuePer share
Share price at each year-end
Tap a line for its trendCurrentlast closeFY24Mar 2024FY23Mar 2023
58.0——
10.010.04.0
2.72.75.1
50.6——
−7.3−7.31.1
₹62.83——
60.360.330.4
4.4%4.4%16.7%
0.05×——
0.68×——
2.61×——
2.92×——
−9.74×——
Reference items — trailing FY values
74.674.658.8
19.419.45.4
17.417.43.5
−5.2−5.23.2
−7.0−7.0−1.3
−7.0−7.0−1.3
1.81.84.5
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

SHUKRAPHAR₹71.92

Shukra Pharmaceuticals Limited

· Pharma & Health
₹ CrorePeersBPLPHARMAJENBURPHKPLMAKERSLNOVARTINDPARNAXLABSGRLSUNLOCMcap ₹58 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
In ₹ Crore except Per Share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
Current
last close
Market Capitalization——58.0
- Cash, Equiv & ST Investments4.010.010.0
+ Total Debt5.12.72.7
Enterprise Value——50.6
Net Debt (memo)1.1-7.3-7.3
EV per Share——62.83
Total Capital30.460.360.3
Total Debt/Total Capital16.734.414.41
Total Debt/EV——0.05
EV/Sales——0.68
EV/EBITDA——2.61
EV/EBIT——2.92
EV/Operating Cash Flow——-9.74
Reference Items — Trailing FY Values
Sales58.874.674.6
EBITDA5.419.419.4
EBIT3.517.417.4
Operating Cash Flow3.2-5.2-5.2
Free Cash Flow-1.3-7.0-7.0
FCFF (free cash flow to the firm)-1.3-7.0-7.0
Capital Expenditure4.51.81.8
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY24 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 85%.